Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Broadcom Inc., 3 years.
Broadcom Inc.
Director
Haemonetics Corporation
Director
Jacobs Solutions Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Haemonetics Corporation July 24, 202699.7%
-
Jacobs Solutions Inc. January 28, 202699.9%
-
Haemonetics Corporation July 24, 202599.4%
-
Broadcom Inc. April 21, 202599.3%
-
Haemonetics Corporation July 25, 202499.6%
-
Broadcom Inc. April 22, 202491.8%
-
Broadcom Inc. April 6, 202390.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 2026 | Haemonetics Corporation | Grant or award | +2,538 | — | — |
| Apr 20, 2026 | Broadcom Inc. | Grant or award | +864 | — | — |
| Jan 29, 2026 | Jacobs Solutions Inc. | Grant or award | +1,636 | $136.29 | $222,970 |
| Jul 24, 2025 | Haemonetics Corporation | Grant or award | +2,693 | — | — |
| Apr 21, 2025 | Broadcom Inc. | Grant or award | +1,602 | — | — |
| Dec 23, 2024 | Broadcom Inc. | Open-market sale | −15,000 | $226.68 | $3,400,200 |
| Jul 25, 2024 | Haemonetics Corporation | Grant or award | +2,207 | — | — |
| Apr 22, 2024 | Broadcom Inc. | Grant or award | +189 | — | — |
| Aug 4, 2023 | Haemonetics Corporation | Grant or award | +2,226 | — | — |
| Apr 3, 2023 | Broadcom Inc. | Grant or award | +397 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.